The effect of mTOR inhibitors on respiratory infections in lymphangioleiomyomatosis - Courtwright, Andrew M.; Goldberg, Hilary J.; Henske, Elizabeth Petri; El-Chemaly, Souheil (European respiratory review, 2017)
Keywords: Humans; Immunocompromised Host; Immunosuppressive Agents - adverse effects; Immunosuppressive Agents - therapeutic use; Incidence; Lymphangioleiomyomatosis - drug therapy; Lymphangioleiomyomatosis - enzymology; Lymphangioleiomyomatosis - epidemiology; Lymphangioleiomyomatosis - immunology; Molecular Targeted Therapy; Opportunistic Infections - epidemiology; Opportunistic Infections - immunology; Opportunistic Infections - prevention & control; Protective Factors; Protein Kinase Inhibitors - adverse effects; Protein Kinase Inhibitors - therapeutic use; Respiratory Tract Infections - epidemiology; Respiratory Tract Infections - immunology; Respiratory Tract Infections - prevention & control; Reviews; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; TOR Serine-Threonine Kinases - antagonists & inhibitors; TOR Serine-Threonine Kinases - metabolism; Treatment Outcome